OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
OneMedNet Corporation (ONMD) announced a 1-for-10 reverse stock split, effective September 29, 2026, to meet Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from ~59.3M to ~5.93M, with trading continuing under the symbol ONMD. The company's platform provides AI-driven Real-World Data for healthcare and life sciences.
How this was made
The 30-second read
Why it matters
The reverse split aims to prevent delisting, likely causing a short‑term price adjustment and altering share‑based compensation structures.
Market read
A corporate action to maintain Nasdaq listing; relevant for traders holding ONMD or monitoring small‑cap compliance trends.
What to watch
Potential dilution from adjusted equity awards and the impact on existing option holders.
Background
OneMedNet provides AI‑driven real‑world healthcare data and needed to meet Nasdaq's minimum bid price.
Ticker impact
OneMedNet announced a 1-for-10 reverse stock split effective Sep 29, 2026 to meet Nasdaq bid price requirements.
Short-term upward pressure as the split is priced in; longer-term impact depends on post‑split liquidity.
Reverse splits are typically priced in quickly; the clear timeline and compliance motive make the effect predictable.
Market effects
May improve perception of Nasdaq‑listed health‑data firms, modestly benefiting peers.
Limited to U.S. small‑cap biotech/tech segment.
Low; primarily a company‑specific compliance action.
Counterpoint
If the split fails to attract new investors, the stock could face volatility and potential downside.
Key entities
- companyOneMedNet Corporation
Provider of regulatory decision‑grade real‑world data.
- service_providerContinental Stock Transfer & Trust Company
Acts as exchange and transfer agent for the split.
